Athelas

Athelas offers a full suite of tools that combine AI-powered automation, remote patient monitoring (RPM), and integrated EHR and billing systems. And its newest platform, Athelas AIR, is a next-generation EHR designed to unify clinical and administrative workflows in one intelligent system. By embedding revenue cycle management (RCM) and ambient AI documentation directly into the platform, Athelas AIR streamlines everything from charting to billing. And the goal is simple, to reduce administrative burden, improve margins, and ultimately, give healthcare teams a smoother, smarter way to work.

The company has made significant strides in recent years. After reaching unicorn status in 2022 and merging with Commure in 2023, Athelas is now valued at around $6B and continues to expand its platform. Alongside growing adoption of Athelas AIR, the company has recently secured FDA clearance for its Athelas Home device - an AI-powered diagnostic tool that delivers lab-grade blood test results from a fingerstick in minutes. This allows care teams to test, diagnose, and make decisions in a single visit. With a growing customer base and a broader push into AI-driven diagnostics as well as software, Athelas is ready to be a leader in end-to-end, intelligent healthcare infrastructure.